Role of ena/VASP proteins in homeostasis and disease

Handbook of Experimental Pharmacology

Volumn 186, Issue , 2008, Pages 39-65

  Pula, G ^a   Krause, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DNA BINDING PROTEIN; ENA/VASP PROTEINS;

ANIMAL; CYTOSKELETON; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; HOMEOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ACTINS; ANIMALS; CYTOSKELETON; DNA-BINDING PROTEINS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HOMEOSTASIS; HUMANS;

EID: 49049104875     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-72843-6_3     Document Type: Article

References (160)

1. Aktas B, Utz A, Hoenig-Liedl P, Walter U, Geiger J (2003) Dipyridamole enhances NO/cGMPmediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Stroke 34:764-769
2. Allen LA, Aderem A (1996) Mechanisms of phagocytosis. Curr Opin Immunol 8:36-40
3. Aszodi A, Pfeifer A, Ahmad M, Glauner M, Zhou XH, Ny L, Andersson KE, Kehrel B, Offermanns S, Fassler R (1999) The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP-and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. Embo J 18:37-48
4. Azizzadeh B, Buga GM, Berke GS, Larian B, Ignarro LJ, Blackwell KE (2003) Inhibitors of nitric oxide promote microvascular thrombosis. Arch Facial Plast Surg 5:31-35
5. Bachmann C, Fischer L, Walter U, Reinhard M (1999) The EVH2 domain of the vasodilatorstimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation. J Biol Chem 274:23549-23557
6. Ball LJ, Kuhne R, Hoffmann B, Hafner A, Schmieder P, Volkmer-Engert R, Hof M, Wahl M, Schneider-Mergener J, Walter U, Oschkinat H, Jarchau T (2000) Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity. EMBO J 19:4903-4914
7. Barzik M, Kotova TI, Higgs HN, Hazelwood L, Hanein D, Gertler FB, Schafer DA (2005) Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem 280:28653-28662.
8. Bashaw GJ, Kidd T, Murray D, Pawson T, Goodman CS (2000) Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor. Cell 101:703-715
9. Baum B, Perrimon N (2001) Spatial control of the actin cytoskeleton in Drosophila epithelial cells. Nat Cell Biol 3:883-890
10. Bear JE, Loureiro JJ, Libova I, Fassler R, Wehland J, Gertler FB (2000) Negative regulation of fibroblast motility by Ena/VASP proteins. Cell 101:717-728
11. Bear JE, Krause M, Gertler FB (2001) Regulating cellular actin assembly. Curr Opin Cell Biol 13:158-166
12. Bear JE, Svitkina TM, Krause M, Schafer DA, Loureiro JJ, Strasser GA, Maly IV, Chaga OY, Cooper JA, Borisy GG, Gertler FB (2002) Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 109:509-521
13. Boukhelifa M, Parast MM, Bear JE, Gertler FB, Otey CA (2004) Palladin is a novel binding partner for Ena/VASP family members. Cell Motil Cytoskeleton 58:17-29
14. Bournier O, Kroviarski Y, Rotter B, Nicolas G, Lecomte MC, Dhermy D (2006) Spectrin interacts with EVL (Enabled/vasodilator-stimulated phosphoprotein-like protein), a protein involved in actin polymerization. Biol Cell 98:279-293
15. Brindle NP, Holt MR, Davies JE, Price CJ, Critchley DR (1996) The focal-adhesion vasodilatorstimulated phosphoprotein (VASP) binds to the proline-rich domain in vinculin. Biochem J 318:753-757
16. Broeders MA, Tangelder GJ, Slaaf DW, Reneman RS, Egbrink MG (1998) Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles. Arterioscler Thromb Vasc Biol 18:139-145
17. Bundschu K, Walter U, Schuh K (2006) The VASP-Spred-Sprouty domain puzzle. J Biol Chem 281:36477-36481
18. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U (1994) cAMP-and cGMPdependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 269:14509-14517
19. Carl UD, Pollmann M, Orr E, Gertlere FB, Chakraborty T, Wehland J (1999) Aromatic and basic residues within the EVH1 domain of VASP specify its interaction with proline-rich ligands. Curr Biol 9:715-718
20. Chakraborty T, Ebel F, Domann E, Niebuhr K, Gerstel B, Pistor S, Temm-Grove CJ, Jockusch BM, Reinhard M, Walter U et al (1995) A focal adhesion factor directly linking intracellularly motile Listeria monocytogenes and Listeria ivanovii to the actin-based cytoskeleton of mammalian cells. EMBO J 14:1314-1321
21. Chen L, Daum G, Chitaley K, Coats SA, Bowen-Pope DF, Eigenthaler M, Thumati NR, Walter U, Clowes AW (2004) Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24:1403-1408
22. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA (2002) Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296:539-541
23. Chereau D, Dominguez R (2006) Understanding the role of the G-actin-binding domain of Ena/VASP in actin assembly. J Struct Biol 155:195-201
24. Chitaley K, Chen L, Galler A, Walter U, Daum G, Clowes AW (2004) Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C. FEBS Lett 556:211-215
25. Comer AR, Ahern-Djamali SM, Juang JL, Jackson PD, Hoffmann FM (1998) Phosphorylation of Enabled by the Drosophila Abelson tyrosine kinase regulates the in vivo function and protein-protein interactions of Enabled. Mol Cell Biol 18:152-160
26. Cook AL, Haynes JM (2007) Phosphorylation of the PKG substrate, vasodilator-stimulated phosphoprotein (VASP), in human cultured prostatic stromal cells. Nitric Oxide 16:10-17
27. Coppolino MG, Krause M, Hagendorff P, Monner DA, Trimble W, Grinstein S, Wehland J, Sechi AS (2001) Evidence for a molecular complex consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcgamma receptor signalling during phagocytosis. J Cell Sci 114:4307-4318
28. Crawford AW, Beckerle MC (1991) Purification and characterization of zyxin, an 82,000-dalton component of adherens junctions. J Biol Chem 266:5847-5853
29. Crittenden JR, Bergmeier W, Zhang Y, Piffath CL, Liang Y, Wagner DD, Housman DE, Graybiel AM (2004) CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 10:982-986
30. Dahl E, Sadr-Nabavi A, Klopocki E, Betz B, Grube S, Kreutzfeld R, Himmelfarb M, An HX, Gelling S, Klaman I, Hinzmann B, Kristiansen G, Grutzmann R, Kuner R, Petschke B, Rhiem K, Wiechen K, Sers C, Wiestler O, Schneider A, Hofler H, Nahrig J, Dietel M, Schafer R, Rosenthal A, Schmutzler R, Durst M, Meindl A, Niederacher D (2005) Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol 205:21-28
31. Danielewski O, Schultess J, Smolenski A (2005) The NO/cGMP pathway inhibits Rap 1 activation in human platelets via cGMP-dependent protein kinase I. Thromb Haemost 93:319-325
32. DeMali KA, Barlow CA, Burridge K (2002) Recruitment of the Arp2/3 complex to vinculin: coupling membrane protrusion to matrix adhesion. J Cell Biol 159:881-891
33. Dertsiz L, Ozbilim G, Kayisli Y, Gokhan GA, Demircan A, Kayisli UA (2005) Differential expression of VASP in normal lung tissue and lung adenocarcinomas. Thorax 60:576-581
34. Di Modugno F, Bronzi G, Scanlan MJ, Del Bello D, Cascioli S, Venturo I, Botti C, Nicotra MR, Mottolese M, Natali PG, Santoni A, Jager E, Nistico P (2004) Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response. Int J Cancer 109:909-918
35. Drees B, Friederich E, Fradelizi J, Louvard D, Beckerle MC, Golsteyn RM (2000) Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins. J Biol Chem 275:22503-22511
36. Egbrink MG, Van Gestel MA, Broeders MA, Tangelder GJ, Heemskerk JM, Reneman RS, Slaaf DW (2005) Regulation of microvascular thromboembolism in vivo. Microcirculation 12:287-300
37. Eigenthaler M, Ullrich H, Geiger J, Horstrup K, Honig-Liedl P, Wiebecke D, Walter U (1993) Defective nitrovasodilator-stimulated protein phosphorylation and calcium regulation in cGMP-dependent protein kinase-deficient human platelets of chronic myelocytic leukemia. J Biol Chem 268:13526-13531
38. Eigenthaler M, Engelhardt S, Schinke B, Kobsar A, Schmitteckert E, Gambaryan S, Engelhardt CM, Krenn V, Eliava M, Jarchau T, Lohse MJ, Walter U, Hein L (2003) Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 285:H2471-H2481
39. Eppert K, Wunder JS, Aneliunas V, Tsui LC, Scherer SW, Andrulis IL (2005) Altered expression and deletion of RMO1 in osteosarcoma. Int J Cancer 114:738-746
40. Ermekova KS, Zambrano N, Linn H, Minopoli G, Gertler F, Russo T, Sudol M (1997) The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila enabled. J Biol Chem 272:32869-32877
41. Fedorov AA, Fedorov E, Gertler F, Almo SC (1999) Structure of EVH1, a novel proline-rich ligand-binding module involved in cytoskeletal dynamics and neural function. Nat Struct Biol 6:661-665
42. FitzGerald GA, Smith B, Pedersen AK, Brash AR (1984) Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 310:1065-1068
43. Frischknecht F, Way M (2001) Surfing pathogens and the lessons learned for actin polymerization. Trends Cell Biol 11:30-38
44. Frojmovic M, Longmire K, van de Ven TG (1990) Long-range interactions in mammalian platelet aggregation. II. The role of platelet pseudopod number and length. Biophys J 58:309-318
45. Gambaryan S, Hauser W, Kobsar A, Glazova M, Walter U (2001) Distribution, cellular localization, and postnatal development of VASP and Mena expression in mouse tissues. Histochem Cell Biol 116:535-543
46. Geiger B (1979) A 130K protein from chicken gizzard: its localization at the termini of microfilament bundles in cultured chicken cells. Cell 18:193-205
47. Gertler FB, Bennett RL, Clark MJ, Hoffmann FM (1989) Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58:103-113
48. Gertler FB, Doctor JS, Hoffmann FM (1990) Genetic suppression of mutations in the Drosophila abl proto-oncogene homolog. Science 248:857-860
49. Gertler FB, Comer AR, Juang JL, Ahern SM, Clark MJ, Liebl EC, Hoffmann FM (1995) Enabled, a dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding properties. Genes Dev 9:521-533
50. Gertler FB, Niebuhr K, Reinhard M, Wehland J, Soriano P (1996) Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87:227-239
51. Gibbs CR, Blann AD, Watson RD, Lip GY (2001) Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 103:1746-1751
52. Gkretsi V, Zhang Y, Tu Y, Chen K, Stolz DB, Yang Y, Watkins SC, Wu C (2005) Physical and functional association of migfilin with cell-cell adhesions. J Cell Sci 118:697-710
53. Golemi-Kotra D, Mahaffy R, Footer MJ, Holtzman JH, Pollard TD, Theriot JA, Schepartz A (2004) High affinity, paralog-specific recognition of the Mena EVH1 domain by a miniature protein. J Am Chem Soc 126:4-5
54. Gouin E, Welch MD, Cossart P (2005) Actin-based motility of intracellular pathogens. Curr Opin Microbiol 8:35-45
55. Grevengoed EE, Loureiro JJ, Jesse TL, Peifer M (2001) Abelson kinase regulates epithelial morphogenesis in Drosophila. J Cell Biol 155:1185-1198.
56. Griffiths EK, Krawczyk C, Kong YY, Raab M, Hyduk SJ, Bouchard D, Chan VS, Kozieradzki I, Oliveira-Dos-Santos AJ, Wakeham A, Ohashi PS, Cybulsky MI, Rudd CE, Penninger JM (2001) Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science 293:2260-2263
57. Gurbel PA, Kereiakes DJ, Dalesandro MR, Bahr RD, O'Connor CM, Serebruany VL (2000) Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department. Am Heart J 139:320-328
58. Halbrugge M, Walter U (1989) Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur J Biochem 185:41-50
59. Halbrugge M, Friedrich C, Eigenthaler M, Schanzenbacher P, Walter U (1990) Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP-and cAMP-elevating vasodilators. J Biol Chem 265:3088-3093
60. Han J, Lim CJ, Watanabe N, Soriani A, Ratnikov B, Calderwood DA, Puzon-McLaughlin W, Lafuente EM, Boussiotis VA, Shattil SJ, Ginsberg MH (2006) Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 16:1796-1806
61. Harbeck B, Huttelmaier S, Schluter K, Jockusch BM, Illenberger S (2000) Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin. J Biol Chem 275:30817-30825
62. Harmer NJ, Sivak JM, Amaya E, Blundell TL (2005) 1.15 A crystal structure of the X. tropicalis Spred1 EVH1 domain suggests a fourth distinct peptide-binding mechanism within the EVH1 family. FEBS Lett 579:1161-1166
63. Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, Geiger J, Glazova M, Rohde E, Horak I, Walter U, Zimmer M (1999) Megakaryocyte hyperplasia and enhanced agonistinduced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci USA 96:8120-8125
64. Hayot C, Debeir O, Van Ham P, Van Damme M, Kiss R, Decaestecker C (2006) Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol Appl Pharmacol 211:30-40
65. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104-1111
66. Hohenstein B, Kasperek L, Kobelt DJ, Daniel C, Gambaryan S, Renne T, Walter U, Amann KU, Hugo CP (2005) Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis. J Am Soc Nephrol 16:986-996
67. Horstrup K, Jablonka B, Honig-Liedl P, Just M, Kochsiek K, Walter U (1994) Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem 225:21-27
68. Howe AK, Hogan BP, Juliano RL (2002) Regulation of vasodilator-stimulated phosphoprotein phosphorylation and interaction with Abl by protein kinase A and cell adhesion. J Biol Chem 277:38121-38126
69. Hunke C, Hirsch T, Eichler J (2006) Structure-based synthetic mimicry of discontinuous protein binding sites: inhibitors of the interaction of Mena EVH1 domain with proline-rich ligands. Chembiochem 7:1258-1264
70. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61-67
71. Huttelmaier S, Harbeck B, Steffens O, Messerschmidt T, Illenberger S, Jockusch BM (1999) Characterization of the actin binding properties of the vasodilator-stimulated phosphoprotein VASP. FEBS Lett 451:68-74
72. Ibarra-Alvarado C, Galle J, Melichar VO, Mameghani A, Schmidt HH (2002) Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling. Mol Pharmacol 61:312-319
73. Isenberg WM, Bainton DF, Newman PJ (1990) Monoclonal antibodies bound to subunits of the integrin GPIIb-IIIa are internalized and interfere with filopodia formation and platelet aggregation. Blood 76:1564-1571
74. Jenzora A, Behrendt B, Small JV, Wehland J, Stradal TE (2005) PREL1 provides a link from Ras signalling to the actin cytoskeleton via Ena/VASP proteins. FEBS Lett 579:455-463
75. Jin RC, Voetsch B, Loscalzo J (2005) Endogenous mechanisms of inhibition of platelet function. Microcirculation 12:247-258
76. Johnson RJ (1991) Platelets in inflammatory glomerular injury. Semin Nephrol 11:276-284
77. Jordan MS, Singer AL, Koretzky GA (2003) Adaptors as central mediators of signal transduction in immune cells. Nat Immunol 4:110-116
78. Kayisli UA, Demir R, Erguler G, Arici A (2002) Vasodilator-stimulated phosphoprotein expression and its cytokine-mediated regulation in vasculogenesis during human placental development. Mol Hum Reprod 8:1023-1030
79. Keicher C, Gambaryan S, Schulze E, Marcus K, Meyer HE, Butt E (2004) Phosphorylation of mouse LASP-1 on threonine 156 by cAMP-and cGMP-dependent protein kinase. Biochem Biophys Res Commun 324:308-316
80. Kirshenbaum K, Barron AE, Goldsmith RA, Armand P, Bradley EK, Truong KT, Dill KA, Cohen FE, Zuckermann RN (1998) Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc Natl Acad Sci USA 95:4303-4308
81. Krause M, Sechi AS, Konradt M, Monner D, Gertler FB, Wehland J (2000) Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J Cell Biol 149:181-194
82. Krause M, Leslie JD, Stewart M, Lafuente EM, Valderrama F, Jagannathan R, Strasser GA, Rubinson DA, Liu H, Way M, Yaffe MB, Boussiotis VA, Gertler FB (2004) Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics. Dev Cell 7:571-583
83. Kuhnel K, Jarchau T, Wolf E, Schlichting I, Walter U, Wittinghofer A, Strelkov SV (2004) The VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat. Proc Natl Acad Sci USA 101:17027-17032
84. Lafuente EM, van Puijenbroek AA, Krause M, Carman CV, Freeman GJ, Berezovskaya A, Constantine E, Springer TA, Gertler FB, Boussiotis VA (2004) RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell 7:585-595
85. Lambrechts A, Verschelde JL, Jonckheere V, Goethals M, Vandekerckhove J, Ampe C (1997) The mammalian profilin isoforms display complementary affinities for PIP2 and proline-rich sequences. Embo J 16:484-494
86. Lambrechts A, Kwiatkowski AV, Lanier LM, Bear JE, Vandekerckhove J, Ampe C, Gertler FB (2000) cAMP-dependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J Biol Chem 275:36143-36151
87. Lambrechts A, Van Troys M, Ampe C (2004) The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol 36:1890-1909
88. Lanier LM, Gates MA, Witke W, Menzies AS, Wehman AM, Macklis JD, Kwiatkowski D, Soriano P, Gertler FB (1999) Mena is required for neurulation and commissure formation. Neuron 22:313-325
89. Laurent V, Loisel TP, Harbeck B, Wehman A, Grobe L, Jockusch BM, Wehland J, Gertler FB, Carlier MF (1999) Role of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes. J Cell Biol 144:1245-1258
90. Lawrence DW, Pryzwansky KB (2001) The vasodilator-stimulated phosphoprotein is regulated by cyclic GMP-dependent protein kinase during neutrophil spreading. J Immunol 166:5550-5556
91. Lawrence DW, Comerford KM, Colgan SP (2002) Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch. Am J Physiol Cell Physiol 282:C1235-C1245
92. Lebrand C, Dent EW, Strasser GA, Lanier LM, Krause M, Svitkina TM, Borisy GG, Gertler FB (2004) Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1. Neuron 42:37-49
93. Li Z, Ajdic J, Eigenthaler M, Du X (2003) A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood 101:4423-4429
94. Lindberg RA, Slaaf DW, Lentsch AB, Miller FN (1994) Involvement of nitric oxide and cyclooxygenase products in photoactivation-induced microvascular occlusion. Microvasc Res 47:203-221
95. Liu K, Li L, Nisson PE, Gruber C, Jessee J, Cohen SN (1999) Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein. Mol Cell Biol 19:3696-3703
96. Loureiro JJ, Rubinson DA, Bear JE, Baltus GA, Kwiatkowski AV, Gertler FB (2002) Critical roles of phosphorylation and actin binding motifs, but not the central proline-rich region, for Ena/vasodilator-stimulated phosphoprotein (VASP) function during cell migration. Mol Biol Cell 13:2533-2546
97. Machesky LM, Hall A (1997) Role of actin polymerization and adhesion to extracellular matrix in Rac-and Rho-induced cytoskeletal reorganization. J Cell Biol 138:913-926
98. Mao X, Kashii T, Hayashi R, Sassa K, Fujishita T, Maruyama M, Kobayashi M, Liu S (2000) Cloning of differentially expressed sequence tags from nickel-transformed human embryonic lung cells. Cancer Lett 161:57-62
99. Markert T, Krenn V, Leebmann J, Walter U (1996) High expression of the focal adhesion-and microfilament-associated protein VASP in vascular smooth muscle and endothelial cells of the intact human vessel wall. Basic Res Cardiol 91:337-343
100. Massberg S, Sausbier M, Klatt P, Bauer M, Pfeifer A, Siess W, Fassler R, Ruth P, Krombach F, Hofmann F (1999) Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I. J Exp Med 189:1255-1264
101. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:887-896
102. Massberg S, Gruner S, Konrad I, Garcia Arguinzonis MI, Eigenthaler M, Hemler K, Kersting J, Schulz C, Muller I, Besta F, Nieswandt B, Heinzmann U, Walter U, Gawaz M (2004) Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood 103:136-142
103. Mejillano MR, Kojima S, Applewhite DA, Gertler FB, Svitkina TM, Borisy GG (2004) Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end. Cell 118:363-373
104. Melichar VO, Behr-Roussel D, Zabel U, Uttenthal LO, Rodrigo J, Rupin A, Verbeuren TJ, Kumar HSA, Schmidt HH (2004) Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc Natl Acad Sci USA 101:16671-16676
105. Menzies AS, Aszodi A, Williams SE, Pfeifer A, Wehman AM, Goh KL, Mason CA, Fassler R, Gertler FB (2004) Mena and vasodilator-stimulated phosphoprotein are required for multiple actin-dependent processes that shape the vertebrate nervous system. J Neurosci 24:8029-8038
106. Moeller MJ, Soofi A, Braun GS, Li X, Watzl C, Kriz W, Holzman LB (2004) Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J 23:3769-3779
107. Monks D, Lange V, Silber RE, Markert T, Walter U, Nehls V (1998) Expression of cGMP-dependent protein kinase I and its substrate VASP in neointimal cells of the injured rat carotid artery. Eur J Clin Invest 28:416-423
108. Niebuhr K, Ebel F, Frank R, Reinhard M, Domann E, Carl UD, Walter U, Gertler FB, Wehland J, Chakraborty T (1997) A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family. EMBO J 16:5433-5444
109. Niedergang F, Chavrier P (2004) Signaling and membrane dynamics during phagocytosis: many roads lead to the phagos(R)ome. Curr Opin Cell Biol 16:422-428
110. Nimpf J, Wurm H, Kostner GM, Kenner T (1986) Platelet activation in normo-and hyperlipoproteinemias. Basic Res Cardiol 81:437-453
111. Nolte C, Eigenthaler M, Schanzenbacher P, Walter U (1991a) Comparison of vasodilatory prostaglandins with respect to cAMP-mediated phosphorylation of a target substrate in intact human platelets. Biochem Pharmacol 42:253-262
112. Nolte C, Eigenthaler M, Schanzenbacher P, Walter U (1991b) Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP-and cGMP-elevating factors. J Biol Chem 266:14808-14812
113. Parangi S, O'Reilly M, Christofori G, Holmgren L, Grosfeld J, Folkman J, Hanahan D (1996) Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci USA 93:2002-2007
114. Pawlak G, Helfman DM (2001) Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 11:41-47
115. Peterson EJ, Woods ML, Dmowski SA, Derimanov G, Jordan MS, Wu JN, Myung PS, Liu QH, Pribila JT, Freedman BD, Shimizu Y, Koretzky GA (2001) Coupling of the TCR to integrin activation by Slap-130/Fyb. Science 293:2263-2265
116. Peterson FC, Deng Q, Zettl M, Prehoda KE, Lim WA, Way M, Volkman BF (2007) Multiple WIP recognition motifs are required for a functional interaction with N-WASP. J Biol Chem 282(11):8446-8453.
117. Prehoda KE, Lee DJ, Lim WA (1999) Structure of the enabled/VASP homology 1 domain-peptide complex: a key component in the spatial control of actin assembly. Cell 97:471-480
118. Price CJ, Brindle NP (2000) Vasodilator-stimulated phosphoprotein is involved in stress-fiber and membrane ruffle formation in endothelial cells. Arterioscler Thromb Vasc Biol 20:2051-2056
119. Pula G, Schuh K, Nakayama K, Nakayama KI, Walter U, Poole AW (2006) PKCγregulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation. Blood 108:4035-4044
120. Quinlan MP (2004) Suppression of epithelial cell transformation and induction of actin dependent differentiation by dominant negative Rac1, but not Ras, Rho or Cdc42. Cancer Biol Ther 3:65-70
121. Rao J, Li N (2004) Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 4:345-354
122. Reinhard M, Giehl K, Abel K, Haffner C, Jarchau T, Hoppe V, Jockusch BM, Walter U (1995) The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. Embo J 14:1583-1589
123. Reinhard M, Rudiger M, Jockusch BM, Walter U (1996) VASP interaction with vinculin: a recurring theme of interactions with proline-rich motifs. FEBS Lett 399:103-107
124. Riba R, Oberprieler NG, Roberts W, Naseem KM (2006) Von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism. J Thromb Haemost 4:2636-2644
125. Rodriguez-Viciana P, Sabatier C, McCormick F (2004) Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 24:4943-4954
126. Rotter B, Bournier O, Nicolas G, Dhermy D, Lecomte MC (2005) AlphaII-spectrin interacts with Tes and EVL, two actin-binding proteins located at cell contacts. Biochem J 388:631-638
127. Salazar R, Bell SE, Davis GE (1999) Coordinate induction of the actin cytoskeletal regulatory proteins gelsolin, vasodilator-stimulated phosphoprotein, and profilin during capillary morphogenesis in vitro. Exp Cell Res 249:22-32
128. Salazar MA, Kwiatkowski AV, Pellegrini L, Cestra G, Butler MH, Rossman KL, Serna DM, Sondek J, Gertler FB, De Camilli P (2003) Tuba: A novel protein containing Bin/Amphiphysin/Rvs (BAR) and Dbl homology domains links dynamin to regulation of the actin cytoskeleton. J Biol Chem 278:49031-49043
129. Schafer A, Burkhardt M, Vollkommer T, Bauersachs J, Munzel T, Walter U, Smolenski A (2003) Endothelium-dependent and-independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta. Biochem Pharmacol 65:397-405
130. Schafer A, Widder J, Eigenthaler M, Ertl G, Bauersachs J (2004) Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats. Biochem Pharmacol 67:2273-2279
131. Schafer A, Fraccarollo D, Eigenthaler M, Tas P, Firnschild A, Frantz S, Ertl G, Bauersachs J (2005) Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability. Arterioscler Thromb Vasc Biol 25:1071-1077
132. Schafer A, Flierl U, Kobsar A, Eigenthaler M, Ertl G, Bauersachs J (2006) Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats. Arterioscler Thromb Vasc Biol 26:2813-2818
133. Schwarz UR, Geiger J, Walter U, Eigenthaler M (1999) Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 82:1145-1152
134. Scott JA, Shewan AM, den Elzen NR, Loureiro JJ, Gertler FB, Yap AS (2006) Ena/VASP proteins can regulate distinct modes of actin organization at cadherin-adhesive contacts. Mol Biol Cell 17:1085-1095
135. Shattil SJ, Kashiwagi H, Pampori N (1998) Integrin signaling: the platelet paradigm. Blood 91:2645-2657
136. Sinnaeve P, Chiche JD, Gillijns H, Van Pelt N, Wirthlin D, Van De Werf F, Collen D, Bloch KD, Janssens S (2002) Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis. Circulation 105:2911-2916
137. Smith GA, Theriot JA, Portnoy DA (1996) The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin. J Cell Biol 135:647-660
138. Smolenski A, Bachmann C, Reinhard K, Honig-Liedl P, Jarchau T, Hoschuetzky H, Walter U (1998) Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273:20029-20035
139. Smolenski A, Poller W, Walter U, Lohmann SM (2000) Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I. J Biol Chem 275:25723-25732
140. Sporbert A, Mertsch K, Smolenski A, Haseloff RF, Schonfelder G, Paul M, Ruth P, Walter U, Blasig IE (1999) Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide-and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes. Brain Res Mol Brain Res 67:258-266
141. Sudo T, Ito H, Kimura Y (2003) Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets. Platelets 14:381-390
142. Tani K, Sato S, Sukezane T, Kojima H, Hirose H, Hanafusa H, Shishido T (2003) Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase. J Biol Chem 278:21685-21692
143. Tanoue T, Takeichi M (2004) Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact. J Cell Biol 165:517-528
144. Tschoepe D, Roesen P, Schwippert B, Gries FA (1993) Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost 19:122-128
145. Tseng SY, Dustin ML (2002) T-cell activation: a multidimensional signaling network. Curr Opin Cell Biol 14:575-580
146. van der Ven PF, Ehler E, Vakeel P, Eulitz S, Schenk JA, Milting H, Micheel B, Furst DO (2006) Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin c and Mena/VASP. Exp Cell Res 312:2154-2167
147. Vasioukhin V, Bauer C, Yin M, Fuchs E (2000) Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 100:209-219
148. Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA (2002) Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich syndrome. Cell 111:565-576
149. Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, Tsuneoka M, Komiya S, Baron R, Yoshimura A (2001) Spred is a Sprouty-related suppressor of Ras signalling. Nature 412:647-651
150. Walders-Harbeck B, Khaitlina SY, Hinssen H, Jockusch BM, Illenberger S (2002) The vasodilator-stimulated phosphoprotein promotes actin polymerisation through direct binding to monomeric actin. FEBS Lett 529:275-280.
151. Wang Y, Lin H, Tullman R, Jewell CF, Jr, Weetall ML, Tse FL (1999) Absorption and disposition of a tripeptoid and a tetrapeptide in the rat. Biopharm Drug Dispos 20:69-75
152. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS (2004) Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 64:8585-8594
153. Warnholtz A, Ostad MA, Velich N, Trautmann C, Schinzel R, Walter U, Munzel T (2007) A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study. Atherosclerosis 196(2):689-695
154. Wentworth JKT, Pula G, Poole AW (2006) Vasodilator-stimulated phosporprotein (VASP) is phosphorylated on SER157 by protein kinase C-dependent and-independent mechanisms in thrombin-stimulated human platelets. Biochem J 393:555-564
155. Winocour PD (1992) Platelet abnormalities in diabetes mellitus. Diabetes 92:26-31
156. Wu C (2005) Migfilin and its binding partners: from cell biology to human diseases. J Cell Sci 118:659-64
157. Zettl M, Way M (2002) The WH1 and EVH1 domains of WASP and Ena/VASP family members bind distinct sequence motifs. Curr Biol 12:1617-1622
158. Zhang Y, Tu Y, Gkretsi V, Wu C (2006) Migfilin interacts with vasodilator-stimulated phosphoprotein (VASP) and regulates VASP localization to cell-matrix adhesions and migration. J Biol Chem 281:12397-12407
159. Zimmermann J, Labudde D, Jarchau T, Walter U, Oschkinat H, Ball LJ (2002) Relaxation, equilibrium oligomerization, and molecular symmetry of the VASP (336-380) EVH2 tetramer. Biochemistry 41:11143-11151
160. Zimmermann J, Kuhne R, Volkmer-Engert R, Jarchau T, Walter U, Oschkinat H, Ball LJ (2003) Design of N-substituted peptomer ligands for EVH1 domains. J Biol Chem 278:36810-36818